Serum thiols as a biomarker of disease activity in lupus nephritis

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Lalwani, Pritesh ^a,b   De Souza, Giselle Katiane Bonfim Bacelar ^a   De Lima, Domingos Savio Nunes ^c   Passos, Luiz Fernando Souza ^a   Boechat, Antonio Luiz ^a   Lima, Emerson Silva ^a  

^a FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

^b INSTITUTO LEÔNIDAS E MARIA DEANE   (Brazil)

^c UNIVERSIDADE DO ESTADO DO AMAZONAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; COMPLEMENT COMPONENT C3; CREATININE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; THIOL; BIOLOGICAL MARKER; THIOL DERIVATIVE;

ADULT; ARTICLE; BLOOD LEVEL; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; KIDNEY FUNCTION TEST; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; SEVERITY OF ILLNESS INDEX;

ADULT; BIOMARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; ROC CURVE; SEVERITY OF ILLNESS INDEX; SULFHYDRYL COMPOUNDS;

EID: 84925680119     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119947     Document Type: Article

References (47)

1. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011 Dec 1; 365(22):2110-21. doi: 10. 1056/NEJMra1100359 PMID: 22129255
2. Pons-Estel GJ, Alarcón GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 2010 Feb; 39(4):257-68. doi: 10.1016/j.semarthrit.2008.10.007 PMID: 19136143
3. Von Herrath MG, Fujinami RS, Whitton JL. Microorganisms and autoimmunity: making the barren field fertile Nat Rev Microbiol. 2003 Dec; 1(2):151-7. PMID: 15035044
4. Sfriso P, Ghirardello A, Botsios C, Tonon M, Zen M, Bassi N, et al. Infections and autoimmunity: the multifaceted relationship. J Leukoc Biol. 2010 Mar; 87(3):385-95. doi: 10.1189/jlb.0709517 PMID: 20015961
5. Raftery MJ, Lalwani P, Krautkrämer E, Peters T, Scharffetter-Kochanek K, Krüger R, et al. β2 integrin mediates hantavirus-induced release of neutrophil extracellular traps. J Exp Med. 2014 Jun 30; 211 (7):1485-97. doi: 10.1084/jem.20131092 PMID: 24889201
6. Vilar MJP, Sato EI. Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil). Lupus. 2002 Jan; 11(8):528-32. PMID: 12220107
7. Contreras G, Roth D, Pardo V, Striker LG, Schultz DR. Lupus nephritis: a clinical review for practicing nephrologists. Clin Nephrol. 2002 Feb; 57(2):95-107. PMID: 11863131
8. Bomback AS, Appel GB. Updates on the treatment of lupus nephritis. J Am Soc Nephrol. 2010 Dec; 21 (12):2028-35. doi: 10.1681/ASN.2010050472 PMID: 21051743
9. Rovin BH, Zhang X. Biomarkers for lupus nephritis: the quest continues. Clin J Am Soc Nephrol. 2009 Nov; 4(11):1858-65. doi: 10.2215/CJN.03530509 PMID: 19729426
10. Moroni G, Radice A, Giammarresi G, Quaglini S, Gallelli B, Leoni A, et al. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis. 2009 Feb 1; 68(2):234-7. doi: 10.1136/ard.2008.094508 PMID: 18718989
11. Sprangers B, Monahan M, Appel GB. Diagnosis and treatment of lupus nephritis flares-an update. Nat Rev Nephrol. Nature Publishing Group; 2012 Dec; 8(12):709-17. doi: 10.1038/nrneph.2012.220 PMID: 23147758
12. Perl A. Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nat Rev Rheumatol. Nature Publishing Group; 2013 Oct 8;1-13.
13. Nathan C, Cunningham-Bussel A. Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat Rev Immunol. 2013 Apr 25; 13(5):349-61. doi: 10.1038/nri3423 PMID: 23618831
14. Zhang Q, Ye DQ, Chen GP, Zheng Y. Oxidative protein damage and antioxidant status in systemic lupus erythematosus. Clin Exp Dermatol. 2010 Apr; 35(3):287-94. doi: 10.1111/j.1365-2230.2009. 03437.x PMID: 19874339
15. Córdova EJ, Velázquez-Cruz R, Centeno F, Baca V, Orozco L. The NRF2 gene variant, -653G/A, is associated with nephritis in childhood-onset systemic lupus erythematosus. Lupus. 2010 Sep; 19 (10):1237-42. doi: 10.1177/0961203310367917 PMID: 20507872
16. Oates JC, Shaftman SR, Self SE, Gilkeson GS. Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis. Arthritis Rheum. 2008 Jan; 58(1):263-72. doi: 10.1002/art.23153 PMID: 18163495
17. Moroni G, Novembrino C, Quaglini S, De Giuseppe R, Gallelli B, Uva V, et al. Oxidative stress and homocysteine metabolism in patients with lupus nephritis. Lupus. 2010 Jan 1; 19(1):65-72. doi: 10.1177/0961203309346906 PMID: 19933721
18. Morgan PE, Sturgess AD, Davies MJ. Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radic Res. 2009 Feb; 43(2):117-27. doi: 10.1080/10715760802623896 PMID: 19096973
19. Turgay M, Durak I, Erten S, Ertugrul E, Devrim E, Avci A, et al. Oxidative stress and antioxidant parameters in a Turkish group of patients with active and inactive systemic lupus erythematosus. APLAR J Rheumatol. 2007 Jun; 10(2):101-6.
20. Shah D, Wanchu A, Bhatnagar A. Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis. Immunobiology. 2011 Sep; 216 (9):1010-7. doi: 10.1016/j.imbio.2011.04.001 PMID: 21601309
21. Pérez YG, Pérez LCG, Netto R de CM, Lima DSN de, Lima ES. Malondialdehyde and sulfhydryl groups as biomarkers of oxidative stress in patients with systemic lupus erythematosus. Rev Bras Reumatol. 2012 Aug; 52(4):658-60. PMID: 22885431
22. Shah D, Sah S, Nath SK. Interaction between glutathione and apoptosis in systemic lupus erythematosus. Autoimmun Rev. 2013 May; 12(7):741-51. doi: 10.1016/j.autrev.2012.12.007 PMID: 23279845
23. Shah D, Mahajan N, Sah S, Nath SK, Paudyal B. Oxidative stress and its biomarkers in systemic lupus erythematosus. J Biomed Sci. Journal of Biomedical Science; 2014 Jan; 21(1):23.
24. Suzuki M, Wiers K, Brooks EB, Greis KD, Haines K, Klein-Gitelman MS, et al. Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis. Pediatr Res. 2009 May; 65(5):530-6. doi: 10.1203/PDR.0b013e31819e4305 PMID: 19218887
25. Yip J, Aghdassi E, Su J, Lou W, Reich H, Bargman J, et al. Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus. J Rheumatol. 2010 Aug 1; 37(8):1667-72. doi: 10. 3899/jrheum.091028 PMID: 20516026
26. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 Sep; 40(9):1725. PMID: 9324033
27. Weening JJ, D'Agati VD, Schwartz MM, Seshan S V, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004 Feb; 15 (2):241-50. PMID: 14747370
28. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 Jun; 35(6):630-40. PMID: 1599520
29. Araujo CF, Lacerda MVG, Abdalla DSP, Lima ES. The role of platelet and plasma markers of antioxidant status and oxidative stress in thrombocytopenia among patients with vivax malaria. Mem Inst Oswaldo Cruz. 2008 Sep; 103(6):517-21. PMID: 18949318
30. Fabbri C, de Cássia Mascarenhas-Netto R, Lalwani P, Melo GC, Magalhães BM, Alexandre M a, et al. Lipid peroxidation and antioxidant enzymes activity in Plasmodium vivax malaria patients evolving with cholestatic jaundice. Malar J. 2013 Sep 10; 12(1):315.
31. Faul F, Erdfelder E, Lang A-G, Buchner A. GPower 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007 May; 39(2):175-91. PMID: 17695343
32. Gwinner W, Gröne H-J. Role of reactive oxygen species in glomerulonephritis. Nephrol Dial Transplant. 2000; 15:1127-32. PMID: 10910434
33. Jones DP. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol. 2008 Oct; 295(4):C849-68. doi: 10.1152/ajpcell.00283.2008 PMID: 18684987
34. Turell L, Radi R, Alvarez B. The thiol pool in human plasma: The central contribution of albumin to redox processes. Free Radic Biol Med. Elsevier; 2013 Jun 7; 65C:244-53.
35. Moriarty-Craige SE, Jones DP. Extracellular thiols and thiol/disulfide redox in metabolism. Annu Rev Nutr. 2004 Jan; 24:481-509. PMID: 15189129
36. Sulkowska M, Sulkowski S, Skrzydlewska E, Farbiszewski R. Cyclophosphamide-induced generation of reactive oxygen species. Comparison with morphological changes in type II alveolar epithelial cells and lung capillaries. Exp Toxicol Pathol. 1998 Jun; 50(3):209-20. PMID: 9681651
37. Park J, Ha H, Seo J, Kim MS, Kim HJ, Huh KH, et al. Mycophenolic acid inhibits platelet-derived growth factor-induced reactive oxygen species and mitogen-activated protein kinase activation in rat vascular smooth muscle cells. Am J Transplant. 2004 Dec; 4(12):1982-90. PMID: 15575900
38. Huh KH, Ahn HJ, Park J, Ju MK, Song JS, Kim MS, et al. Mycophenolic acid inhibits oleic acid-induced mesangial cell activation through both cellular reactive oxygen species and inosine monophosphate dehydrogenase 2 pathways. Pediatr Nephrol. 2009 Apr; 24(4):737-45. doi: 10.1007/s00467-008-1075-8 PMID: 19093139
39. Abraham P, Isaac B, Ramamoorthy H, Natarajan K. Oral glutamine attenuates cyclophosphamide-induced oxidative stress in the bladder but does not prevent hemorrhagic cystitis in rats. J Med Toxicol. 2011 Jun; 7(2):118-24. doi: 10.1007/s13181-010-0103-9 PMID: 20661687
40. Herrera J, Ferrebuz A, MacGregor EG, Rodriguez-Iturbe B. Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis. J Am Soc Nephrol. 2006 Dec; 17(12 Suppl 3):S218-25. PMID: 17130265
41. Shah D, Sah S, Wanchu A, Wu MX, Bhatnagar A. Altered redox state and apoptosis in the pathogenesis of systemic lupus erythematosus. Immunobiology. Elsevier GmbH.; 2013 Apr; 218(4):620-7. doi:10.1016/j.imbio.2012.07.030 PMID: 22940256
42. Yardim-Akaydin S, Sepici A, Ozkan Y, Torun M, Simek B, Sepici V. Oxidation of uric acid in rheumatoid arthritis: is allantoin a marker of oxidative stress? Free Radic Res. 2004 Jun; 38(6):623-8. PMID: 15346653
43. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007 Jan; 39(1):44-84. PMID: 16978905
44. Zhang J, Ma K, Wang H. Cyclophosphamide suppresses thioredoxin reductase in bladder tissue and its adaptive response via inductions of thioredoxin reductase and glutathione peroxidase. Chem Biol Interact. 2006 Jul 25; 162(1):24-30. PMID: 16797508
45. Gambhir JK, Lali P, Jain AK. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem. 1997 Jun; 30(4):351-5. PMID: 9209794
46. Mansour R Ben, Lassoued S, Gargouri B, El Gaïd A, Attia H, Fakhfakh F. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Scand J Rheumatol. 2008; 37(2):103-8. doi: 10.1080/03009740701772465 PMID: 18415766
47. Giannouli S, Voulgarelis M, Ziakas PD, Tzioufas AG. Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment. Ann Rheum Dis. 2006 Feb; 65(2):144-8. PMID: 16079164